Two Sigma Investments’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
Other funds holding BCYC
BBA
LFCM
Two Sigma Investments's BCYC Position: Q3 2026 in Review
Two Sigma Investments increased its Bicycle Therapeutics (BCYC) stake by 157% in Q3 2026, buying an estimated $2.77M and bringing the position to 1,118,717 shares worth $4.12M. The position accounts for ﹤0.01% of the portfolio, ranked #2360.
Two Sigma Investments first reported a position in BCYC in Q4 2020 and has held it in 18 quarters since. The position peaked at $9.21M in Q4 2021. 90 funds tracked by Wall St. Rank hold BCYC as of Q3 2026.
- Two Sigma Investments held 1,118,717 shares of Bicycle Therapeutics worth $4.12M as of Q3 2026.
- Two Sigma Investments bought 684,140 Bicycle Therapeutics shares in Q3 2026, an estimated $2.77M.
- Bicycle Therapeutics made up ﹤0.01% of Two Sigma Investments's portfolio in Q3 2026, its #2360 holding.
- Two Sigma Investments first reported a position in Bicycle Therapeutics in Q4 2020 and has held it in 18 quarters since.
- Two Sigma Investments's Bicycle Therapeutics position peaked at $9.21M in Q4 2021.
- 90 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q3 2026.
Based on Two Sigma Investments's 13F filing for Q3 2026, filed 16 Nov 2026.